Research programme: ion channel inhibitors - Newron

Drug Profile

Research programme: ion channel inhibitors - Newron

Alternative Names: Ion channel antagonists - Newron; Ion channel inhibitors - Newron

Latest Information Update: 11 Aug 2011

Price : $50

At a glance

  • Originator Newron Pharmaceuticals
  • Class
  • Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Research CNS disorders; Neuropathic pain; Pain

Most Recent Events

  • 11 Aug 2011 Research is ongoing in Italy
  • 08 Oct 2008 Newron Pharmaceuticals receives a grant from the Italian government to support the company's ongoing R&D programme and training activities
  • 17 Aug 2007 Early research in Neuropathic pain in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top